Several Hadassah University Medical Center medical professionals have won prestigious awards and gained recognition internationally.
A woman with terminal bone marrow failure was saved at the Hadassah Medical Center with placental stem cell therapy, marking the second successful treatment of a patient with this life-threatening medical condition in three months.
Cell Cure Neurosciences Ltd., whose Chief Scientific Officer is Hadassah University Medical Center’s Prof. Benjamin Reubinoff--Director of its Human Embryonic Stem Cell Research Center--received a 1.3 million-dollar grant from Israel's Office of the Chief Scientist (OCS) to help finance its development of a treatment for age-related macular degeneration (AMD).
Noting that Vitamin D deficiency is “highly prevalent” in patients with heart failure (HF) and “a significant predictor of reduced survival,” Hadassah Medical Center physicians determined that Vitamin D supplementation was associated with improved outcome.
Actress and Hadassah International Ambassador Veronica Ferres presents a check for 125,000 euros from her game show winnings to Prof. Eitan Kerem, head of Pediatrics at the Hadassah University Medical Center.
The Bordet Institute of the Free University of Brussels, Belgium and the Hadassah University Medical Center have signed an agreement of cooperation to advance cancer research
Peter Hudson, Australian football icon, visited Hadassah Hospital Ein-Kerem in July and spent some time with Dr. Yigal Shoshan, head of Neurosurgery at Hadassah.
In the last decade, researchers in neurology, neurosurgery and related fields have made major advances in understanding the mind and the impact of diseases and disorders on its many functions. Heightened understanding has led to changes in treatment protocols and advances in treatments themselves. Prof. Tamir Ben-Hur, Head of the Department of Neurology, was the driving force behind the creation of Hadassah’s Comprehensive Epilepsy Center, one of the many places where this new approach is especially evident.
A new treatment for amyotrophic lateral sclerosis (ALS) based on stem cell technology and now in clinical trials at the Hadassah University Medical Center, appears to have cured an Orthodox Rabbi in Israel who was diagnosed with the disease two years ago.
When Prof. Chaim Lotan, Director of the Hadassah University Medical Center’s Heart Institute, met Souad Mekhennet, a reporter for The New York Times, who was in Jerusalem to cover an international event, he invited her to visit Hadassah. When she met with Ron Krumer, Director of External Affairs for Hadassah, she explained that her role as a columnist for the international edition of theTimes was to write about Moslem women. Mr. Krumer arranged for her to speak with several Palestinian women who work at Hadassah.